Addiction Audio9 Huhti 2024

Xylazine, heroin and drug markets with Caroline Copeland

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entered the US drug market but has been increasingly identified in Europe and the UK, even being identified in vapes sold as containing tetrahydrocannabinol (THC). Caroline covers the harms from xylazine and the implications for public health practitioners before relating the UK issues to wider global drug markets.

"The other really nasty thing that xylazine does is that it can cause blood vessels to contract, and our tissues need blood.....to survive, and if we're closing off those blood vessels, that tissue is going to die and it's going to turn into sores on your skin. And if they get infected it can lead to amputation"

Dr Caroline Copeland is a senior lecturer in pharmacology and toxicology at King’s College London and the director of the National Programme on Substance Use Mortality.

Original article: Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies, triangulating from toxicology, drug testing and law enforcement by Caroline Copeland and colleagues. Published in Addiction (2024)

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(129)

MDMA, anxiety, and depression with Zachary Bryant

In this episode, Dr Tsen Vei Lim talks to Zachary Bryant, a PhD candidate at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Australia. The interview covers Z...

31 Loka 202517min

Retention in buprenorphine treatment with Albert Burgess-Hull

In this episode, Dr Elle Wadsworth talks to Dr Albert Burgess-Hull, the Scientific Director of SUDx and Head Data Scientist at MATClinics, US. The interview covers a short report examining treatment r...

24 Loka 202516min

What works for treating cannabis use disorder with Monika Halicka

In this episode, Dr Chloe Burke talks to Dr Monika Halicka, a Senior Research Associate at the Bristol Medical School, University of Bristol, UK. The interview covers a systematic review and meta-anal...

17 Loka 202513min

Genetic influence in addiction with Wei Deng

In this episode, Dr Tsen Vei Lim speaks to Dr Wei Deng, an assistant professor from McMaster University and St Joseph’s Healthcare Hamilton, Canada. The interview covers the research article Wei led e...

19 Syys 202519min

Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

In this episode, Dr Elle Wadsworth speaks to Professor Owen Bowden-Jones from Central North-West London NHS Foundation and Mr Arun Sahai from Guy’s and St Thomas’ Hospitals NHS Trust, both in the UK. ...

5 Syys 202520min

Correcting misperceptions about vaping with Katie East

In this episode, Dr Tsen Vei Lim talks to Dr Katie East, an Associate Professor in Public Health within the Department of Primary Care and Public Health at Brighton and Sussex Medical School in the UK...

29 Elo 202516min

Caregiver alcohol use and child maltreatment with June Leung

In this episode, Dr Zoe Swithenbank speaks to Dr June Leung, a senior researcher at the SHORE and Whariki Research Centre at Massey University in New Zealand. The interview covers June’s systematic re...

22 Elo 202518min

Access to recreational cannabis in Switzerland with Lavinia Baltes

In this episode, Dr Tsen Vei Lim talks to Dr Lavinia Baltes, Head of Research at the Clinic for Psychiatry and Psychotherapy, Psychiatric Services Aargau, Switzerland. The interview covers her researc...

8 Elo 202514min